跳至主要内容
临床试验/NCT02367391
NCT02367391已完成不适用

Pilot Randomized Trial of an Automated Smoking Cessation Intervention Via Mobile Phone Text Messages as an Adjunct to Varenicline in Primary Care

Milton S. Hershey Medical Center2 个研究点 分布在 1 个国家目标入组 152 人开始时间: 2015年1月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
152
试验地点
2
主要终点
Sustained Abstinence at the 12-week Follow up

研究概览

简要总结

This study is evaluating the feasibility and short term smoking cessation outcomes of an automated smoking cessation intervention delivered via mobile phone text messaging as an adjunct to Varenicline in a primary care setting.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Investigator)

入排标准

年龄范围
21 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Smoke >4 cigarettes/day for at least 6 months
  • Want to quit and ready to try in next 30 days
  • Willing to quit all forms of tobacco (including e-cigs)
  • Willing to use Chantix to try to quit
  • Have a cell phone able to receive text messages
  • Willing to attend 3 visits and use varenicline for smoking cessation
  • Plan to live in local area for next 6 months
  • Read and write in English
  • Women not pregnant and taking steps to avoid
  • Able to understand and willing to sign consent

排除标准

  • History of allergic reaction or other adverse event while using varenicline
  • Used a smoking cessation aid/medicine in past 1 month (including e-cigs)
  • Currently pregnant or nursing
  • Does not have a mobile phone that can send and receive text messages or unwilling to receive study texts
  • Uncontrolled serious mental illness or substance abuse or inpatient treatment for these in the past 6 months
  • Uses non-cigarette tobacco products and does not plan to quit all tobacco.
  • Has a history of kidney problems or receives dialysis
  • Had any thoughts that they would be better off dead or of deliberate self-harm in the prior 4 weeks
  • Had a heart attack in the past 4 weeks
  • Mental conditions that would prohibit the participant from completing the protocol

结局指标

主要结局

Sustained Abstinence at the 12-week Follow up

时间窗: 12 weeks

Point Prevalence of 7-day Tobacco Abstinence Biochemically Validated by Exhaled CO < 10ppm at Visit 3 (12 Weeks After Target Quit Day)

时间窗: 12 weeks

Number of Days of Varenicline Use

时间窗: 12 weeks

Number of Active Smoking Cessation Activities Used

时间窗: 12 weeks

Number of activities completed out of 6

次要结局

  • Time (in Days) to Relapse After the Target Quit Day(12 weeks)
  • Total Score on the Positive Smoking Cessation Activities Measure(12 weeks)
  • Continuous Lapse-free Tobacco Abstinence From 4 Weeks to 12 Weeks, Biochemically Validated at Visit 2 and Visit 3.(12 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Jonathan Foulds

Professor

Milton S. Hershey Medical Center

研究点 (2)

Loading locations...

相似试验